Hematology & Medical Oncology Practice Updates and Board Review 2025 | Mayo Clinic School of Continuous Professional Development | CME Course Conference

February 3 – 7, 2025 – The Ritz Carlton Maui – Kapalua, Hawaii This course offers Live (in-person) and Livestream (virtual) attendance options. The Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review course is designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical

Read the full article here

Source: ce.mayo.edu

Categories: Hem/Oncs, General Medicine News

Tweets with this article

Kathryn Ruddy

Join us in Hawaii (or via livestream) Feb. 3-7, 2025 for the Mayo Clinic Hematology & Medical Oncology Practice Updates & Board Review! @MayoHemeOnc @MayoClinic @OncoThor @RManochakian Register here: https://t.co/xLrLNjeuzl

The Human Cost of Inaction on PBM Reform – DC Journal – InsideSources

The case against pharmacy benefit managers (PBMs) and for much-needed reforms of our broken prescription drug pricing system has been convincingly made.

Susannah E. Koontz November 23, 2024

A Woman’s Journey is empowering women to make informed health care decisions

Dr. Kendall Moseley joins us with information on bone health and how aging can affect women’s bone strength and loss.

Mohamad Allaf November 23, 2024

Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial | Journal of Clinical Oncology

PURPOSETo investigate whether intermittent treatment after an induction phase of first-line schedule of fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus panitumumab (PAN) prevents or delays the…

Pashtoon Kasi MD, MS November 23, 2024

What’s next in cancer care — Harvard Gazette

In the “Harvard Thinking” podcast, experts discuss advances in technology from genomic sequencing to AI to personalized vaccines.

Wafik S. El-Deiry, MD, PhD, FACP November 23, 2024

Dr Pant on the Importance of Targeted Therapy and Mutation Testing in Pancreatic Cancer

Shubham Pant, MD, MBBS, discusses next-generation sequencing in pancreatic cancer, highlighting the importance of targeting RAS mutations when applicable.

Anirban Maitra November 23, 2024

Trump picks Johns Hopkins surgeon Makary to run FDA

Makary is a close ally of Robert F. Kennedy Jr. and a proponent of his “Make America Healthy Again” movement to fight chronic diseases.

Anirban Maitra November 23, 2024

A simple suggestion for RFK Jr to end corruption in medicine

If you advise HHS you can’t stuff your pockets with Pharma cash

Vinay Prasad November 23, 2024

Astrogliosis and neuroinflammation underlie scoliosis upon cilia dysfunction

Brain ventricular astrogliosis and neuroinflammation precede scoliosis onset in the zebrafish rpgrip1l ciliary mutant and anti-inflammatory treatment drastically reduces scoliosis while correcting urotensin related peptide…

Seth Corey, MD MPH November 23, 2024

CAR-PRISM (PRecision Intervention Smoldering Myeloma): A Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in High-Risk Smoldering Myeloma | Dana-Farber Cancer Institute

The goal of this research study is to test if ciltacabtagene autoleucel (cilta-cel) is safe and effective in treating participants with high-risk, smoldering myeloma. The…

Aaron Goodman - “Papa Heme” November 23, 2024

Cancer specialist faked data in at least ten papers, VA and UCLA find

Alan Lichtenstein A multiple myeloma specialist “recklessly“ falsified data in at least 10 published articles, according to a joint investigation by the University of California,…

Wafik S. El-Deiry, MD, PhD, FACP November 23, 2024

Related Articles